Samuel O'Brient

Samuel O'Brient

Expertise: Global Financial Markets, Macroeconomics and Geopolitics

Education: BA, Economics & Political Science, Sarah Lawrence College; MSc, International Politics, Trinity College Dublin

Awards & Accomplishments: Published in Curlew Quarterly. Quoted in Forbes. Interviewed by Foreign Policy.

About Samuel
Samuel O’Brient is a Reporter for InvestorPlace, where his work focuses primarily on financial markets, global economic trends, and public policy. O’Brient writes a weekly column on recent political news that investors should be following.

From his early days at InvestorPlace, O’Brient found himself drawn to the booming world of electric vehicles and green energy. His coverage of mining and other battery components has made him an expert source for industry publications. During his early years as an Economic Policy Analyst at U.S. Resist News, he gained expertise in international trade as the U.S.-China trade war dominated headlines. This in-depth research and analysis experience helped strengthen his prowess in all things political economy. O’Brient brings this expertise to work with him every day, thoughtfully analyzing how the daily happenings on the Capitol trickle down to Wall Street… and how retail investors can take action to profit.

An experienced journalist, editor, and economic policy analyst, O’Brient has spent his career guided by a deep passion for economic theory and policy. As a financial blogger on TipRanks, he has received 4.6 stars and is ranked in the top 10% of stock pickers.

O’Brient’s work on economic and tech policy has been curated by popular outlets Marker, OneZero and Gen.

He can be reached on LinkedIn and Muck Rack.

Recent Articles

TMC Stock: What Is Going on With The Metals Company After Its SPAC Merger?

Since the merger that took it public, The Metals Company has seen plenty of turbulence. The future may not be less rocky for TMC stock.

OCGN Stock: Why Ocugen Shares Are Shooting Higher Today

The WHO could be about to green light a vaccine from one of Ocugen's partners, but that doesn't mean OCGN stock will stay in the green.

Dear SPRT Stock Fans, Mark Your Calendars for a Final Catalyst on Sept. 14

These two companies are about to close this deal and move forward, giving SPRT stock the support it needs.

ITMR Stock: The $538M Reason Why Itamar Medical Is Soaring 45% on Monday

ZOLL Medical isn't sleeping on the chance to acquire sleep apnea pioneer Itamar. Shares of ITMR stock are reacting well to the news.

LPTX Stock: Why Leap Therapeutics Just Soared 30% to Start the Day

This company has announced that it will be presenting promising data and shares of LPTX stock have taken a leap.